National and Kapodistrian University of Athens
Design and Synthesis of Inflammasome Inhibitors with potential cardioprotective activity
Abstract
dc:descriptionCardiovascular disease (CVD) is one of the main global death causes, initiated by numerous factors, including atherosclerosis and vascular inflammation. The interconnection of CVD and inflammation is becoming more evident the last decade, where the activation of a cellular pathway by various stimuli, such as alteration of the extracellular ATP concentration, leads to the formation of a multiprotein complex, the inflammasome, and ultimately to the secretion of the cytokine IL-1β. IL-1β is a key modulator of vascular inflammation and may accelerate the atherosclerotic process. In this thesis, we focused on the inhibition of the inflammasome complex, targeting two steps of the inflammatory process; the membrane P2X7 purinergic receptor, which forms a macropore non-selectively permeable to cations and larger molecules, and the NLRP3 inflammasome, which regulates the IL-1β release. The potential inhibitors of the inflammatory pathway bear also NO or H2S donor groups that are proved to negatively regulate the NLRP3 inflammasome formation and may enhance the anti-inflammatory activity. Two generations of P2X7R inhibitors were designed and synthesized. The first generation included adamantane-based amides and its bioisosteres 1,2,3-triazoles. Reported literature data along with the development of a ligand-based pharmacophore model indicated structural features and substitutions of the new analogues for effective inhibition of the receptor. The second generation aimed to replace adamantane with scaffolds that could improve the blocking activity of the novel compounds. Based on derivatives that revealed a high pharmacophore fit-score, we selected the 3-fluoro-4-(trifluoromethyl)phenyl and aryl-substituted cyclohexyl moieties in place of adamantane. All the new compounds were biologically evaluated for their inhibitory activity on P2X7R through electrophysiological experiments, using Xenopus oocytes incubated with the physiological agonist of P2X7, ATP. The results on the bioactivity of the first and second generation indicated the cyclohexyl derivatives to be the most active against the formation of the P2X7 cation channel, irrespective of the substituents’ size and nature. Along with the synthesis of the second generation, crystal structures of a mammalian P2X7 receptor, the pdP2X7 (Ailuropoda melanoleuca, giant panda), which presents comparable characteristics to human P2X7, were published and allowed the construction of a homology model, in order to study the crucial interactions for effective binding to this receptor. The analogues that exhibited the highest inhibitory activity were subjected to molecular docking studies and their favorable interactions were exploited, for the improvement of the developed homotrimer model. Purine analogues were synthesized in order to examine their role on the formation of the NLRP3 inflammasome. Preliminary results of our research group have shown that 6-piperazinyl-purine derivatives, bearing a nitrate ester group, display cardioprotective and anti-inflammatory activity. Since the exact mechanism was not elucidated, the development of a series of additional purine analogues, bearing potential NO or H2S donor groups and diverse structural features, was performed in the context of this thesis to investigate their mechanism of action. The new compounds were tested for their biological activity by measuring their effect on the LPS induced IL-1β secretion levels on aortic smooth muscle cells. Preliminary results of this study have indicated purine analogues bearing nitrate ester groups and a long chain linker as moderate inhibitors of the IL-1β release. A short chain linking the nitrate ester group with the purine core did not favor the inhibition, whereas direct attachment of furoxan on piperazine increased the basal IL-1β levels. The biological assessment of the potential H2S donor analogues highlighted a purine analogue with a 6-carbon atom chain as the most potent among the investigated compounds.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pournara, Dimitra
- Πουρνάρα, Δήμητρα
Subjects
dc:subject × 14- φλεγμονόσωμα NLRP3
- ανταγωνιστές υποδοχέα P2X7
- 6-πιπεραζινυλο-πουρίνες
- δότες μονοξειδίου το αζώτου (NO)
- δότες υδρόθειου (H2S)
- NLRP3 inflammasome
- P2X7 receptor inhibitors
- 6-piperazinyl-purines
- nitric oxide (NO) donors
- hydrogen sulfide (H2S) donors
- Φυσικές Επιστήμες
- Χημεία
- Natural Sciences
- Chemical Sciences
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45305